Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: the intriguing case of Mister B.
Curtò
L
L
Ragonese
M
M
Losa
M
M
Trimarchi
F
F
Cannavò
S
S
D000236:Adenoma / Q000188:drug therapy* / Q000378:metabolism*; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D019382:Human Growth Hormone / Q000031:analogs & derivatives / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D013972:Thyrotropin / Q000378:metabolism*
D003692:Delayed-Action Preparations; D019382:Human Growth Hormone; D013972:Thyrotropin; C406545:pegvisomant; D015282:Octreotide